AMGEN INC is 28.5x more valuable than Immunovant, Inc. by market capitalization ($182.28 B vs $6.40 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IMVT | AMGN |
|---|---|---|
| Market cap | $6.40 B | $182.28 B |
| US-listed rank | #1219 | #80 |
| Revenue (latest FY) | - | $36.75B |
| Net income (latest FY) | -$505.61M | $7.71B |
| Net margin | - | 21.0% |
| P/E (trailing FY) | - | 23.6 |
| SEC filings | 611 | 1,011 |
AMGEN INC is 28.5x more valuable than Immunovant, Inc. by market capitalization ($182.28 B vs $6.40 B).
Full pages: Immunovant, Inc. and AMGEN INC, or browse the full rankings.